Sindrome serotoninergica (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sindrome serotoninergica" in Italian language version.

refsWebsite

Global rank Italian rank

50nih.gov

4^th place

9^th place

17doi.org

2^nd place

7^th place

14archive.org

6^th place

8^th place

13oadoi.org

799^th place

22^nd place

1thelancet.com

2,393^rd place

2,216^th place

1web.archive.org

1^st place

1informaworld.com

low place

8,554^th place

1erowid.org

3,887^th place

3,129^th place

archive.org

U. Braun, DA. Kalbhen, Evidence for the biogenic formation of amphetamine derivatives from components of nutmeg., in Pharmacology, vol. 9, n. 5, 1973, pp. 312-6, PMID 4737998.
SD. Karki, GR. Masood, Combination risperidone and SSRI-induced serotonin syndrome., in Ann Pharmacother, vol. 37, n. 3, marzo 2003, pp. 388-91, PMID 12639169.
EJ. Dunkley, GK. Isbister; D. Sibbritt; AH. Dawson; IM. Whyte, The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity., in QJM, vol. 96, n. 9, settembre 2003, pp. 635-42, PMID 12925718.
J. Fraser, M. South, Life-threatening fluvoxamine overdose in a 4-year-old child., in Intensive Care Med, vol. 25, n. 5, maggio 1999, p. 548, PMID 10401959.
H. Sternbach, The serotonin syndrome., in Am J Psychiatry, vol. 148, n. 6, giugno 1991, pp. 705-13, PMID 2035713.
PK. Gillman, A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status., in Hum Psychopharmacol, vol. 21, n. 2, marzo 2006, pp. 117-25, DOI:10.1002/hup.750, PMID 16342227.
RG. Wenzel, S. Tepper; WE. Korab; F. Freitag, Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?, in Ann Pharmacother, vol. 42, n. 11, novembre 2008, pp. 1692-6, DOI:10.1345/aph.1L260, PMID 18957623.
HS. Duggal, J. Fetchko, Serotonin syndrome and atypical antipsychotics., in Am J Psychiatry, vol. 159, n. 4, aprile 2002, pp. 672-3, PMID 11925312.
M. Gill, F. LoVecchio; B. Selden, Serotonin syndrome in a child after a single dose of fluvoxamine., in Ann Emerg Med, vol. 33, n. 4, aprile 1999, pp. 457-9, PMID 10092727.
E. Vuori, JA. Henry; I. Ojanperä; R. Nieminen; T. Savolainen; P. Wahlsten; M. Jäntti, Death following ingestion of MDMA (ecstasy) and moclobemide., in Addiction, vol. 98, n. 3, marzo 2003, pp. 365-8, PMID 12603236.
JA. OATES, A. SJOERDSMA, Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor., in Neurology, vol. 10, dicembre 1960, pp. 1076-8, PMID 13730138.
IM. Whyte, AH. Dawson; NA. Buckley, Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants., in QJM, vol. 96, n. 5, maggio 2003, pp. 369-74, PMID 12702786.
BC. Prator, Serotonin syndrome., in J Neurosci Nurs, vol. 38, n. 2, aprile 2006, pp. 102-5, PMID 16681290.
V. Chechani, Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy., in Crit Care Med, vol. 30, n. 2, febbraio 2002, pp. 473-6, PMID 11889332.

doi.org

dx.doi.org

EW. Boyer, M. Shannon, The serotonin syndrome., in N Engl J Med, vol. 352, n. 11, marzo 2005, pp. 1112-20, DOI:10.1056/NEJMra041867, PMID 15784664.
PK. Gillman, A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action., in Biol Psychiatry, vol. 59, n. 11, giugno 2006, pp. 1046-51, DOI:10.1016/j.biopsych.2005.11.016, PMID 16460699.
Turk, Wilson, Cahana., Treatment of chronic non-cancer pain, in Lancet, vol. 377, 2011, DOI:10.1016/S0140-6736(11)60402-9.
D. Isenberg, SC. Wong; JA. Curtis, Serotonin syndrome triggered by a single dose of suboxone., in Am J Emerg Med, vol. 26, n. 7, settembre 2008, pp. 840.e3-5, DOI:10.1016/j.ajem.2008.01.039, PMID 18774063.
Francis B, Harchelroad F, LSD/Fluoxetine induced serotonin syndrome, in J Toxicol Clin Toxicol, vol. 34, n. 5, 1996, p. 560, DOI:10.3109/15563659609028019.
M. Steinberg, AK. Morin, Mild serotonin syndrome associated with concurrent linezolid and fluoxetine., in Am J Health Syst Pharm, vol. 64, n. 1, gennaio 2007, pp. 59-62, DOI:10.2146/ajhp060227, PMID 17189581.
C. Sun-Edelstein, SJ. Tepper; RE. Shapiro, Drug-induced serotonin syndrome: a review., in Expert Opin Drug Saf, vol. 7, n. 5, settembre 2008, pp. 587-96, DOI:10.1517/14740338.7.5.587, PMID 18759711.
GK. Isbister, F. Downes; IM. Whyte, Olanzapine and serotonin toxicity., in Psychiatry Clin Neurosci, vol. 57, n. 2, aprile 2003, pp. 241-2, DOI:10.1046/j.1440-1819.2003.01110.x, PMID 12667176.
PK. Gillman, A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status., in Hum Psychopharmacol, vol. 21, n. 2, marzo 2006, pp. 117-25, DOI:10.1002/hup.750, PMID 16342227.
EL. Thorpe, AF. Pizon; MJ. Lynch; J. Boyer, Bupropion induced serotonin syndrome: a case report., in J Med Toxicol, vol. 6, n. 2, giugno 2010, pp. 168-71, DOI:10.1007/s13181-010-0021-x, PMID 20238197.
PK. Gillman, Bupropion, bayesian logic and serotonin toxicity., in J Med Toxicol, vol. 6, n. 2, giugno 2010, pp. 276-7, DOI:10.1007/s13181-010-0084-8, PMID 20440594.
RG. Wenzel, S. Tepper; WE. Korab; F. Freitag, Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?, in Ann Pharmacother, vol. 42, n. 11, novembre 2008, pp. 1692-6, DOI:10.1345/aph.1L260, PMID 18957623.
K. Laine, T. Heikkinen; U. Ekblad; P. Kero, Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations., in Arch Gen Psychiatry, vol. 60, n. 7, luglio 2003, pp. 720-6, DOI:10.1001/archpsyc.60.7.720, PMID 12860776.
Whyte IM, Dawson AH, Redefining the serotonin syndrome [abstract], in J Toxicol Clin Toxicol, vol. 40, n. 5, 2002, pp. 668–9, DOI:10.1081/CLT-120016859.
PK. Gillman, The spectrum concept of serotonin toxicity., in Pain Med, vol. 5, n. 2, giugno 2004, pp. 231-2; author reply 233, DOI:10.1111/j.1526-4637.2004.04033.x, PMID 15209988.
K. Nisijima, K. Shioda; T. Iwamura, Neuroleptic malignant syndrome and serotonin syndrome., in Prog Brain Res, vol. 162, 2007, pp. 81-104, DOI:10.1016/S0079-6123(06)62006-2, PMID 17645916.
N. Bonetto, L. Santelli; L. Battistin; A. Cagnin, Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum., in Cephalalgia, vol. 27, n. 12, dicembre 2007, pp. 1421-3, DOI:10.1111/j.1468-2982.2007.01430.x, PMID 17868285.

erowid.org

Erowid Yohimbe Vaults : Notes on Yohimbine by William White, su erowid.org, 1994. URL consultato il 25 aprile 2013.

informaworld.com

Francis B, Harchelroad F, LSD/Fluoxetine induced serotonin syndrome, in J Toxicol Clin Toxicol, vol. 34, n. 5, 1996, p. 560, DOI:10.3109/15563659609028019.

nih.gov

ncbi.nlm.nih.gov

EW. Boyer, M. Shannon, The serotonin syndrome., in N Engl J Med, vol. 352, n. 11, marzo 2005, pp. 1112-20, DOI:10.1056/NEJMra041867, PMID 15784664.
PK. Gillman, A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action., in Biol Psychiatry, vol. 59, n. 11, giugno 2006, pp. 1046-51, DOI:10.1016/j.biopsych.2005.11.016, PMID 16460699.
GK. Isbister, NA. Buckley; IM. Whyte, Serotonin toxicity: a practical approach to diagnosis and treatment., in Med J Aust, vol. 187, n. 6, settembre 2007, pp. 361-5, PMID 17874986.
JM. Brensilver, L. Smith; CS. Lyttle, Impact of the Libby Zion case on graduate medical education in internal medicine., in Mt Sinai J Med, vol. 65, n. 4, settembre 1998, pp. 296-300, PMID 9757752.
E. Sampson, JP. Warner, Serotonin syndrome: potentially fatal but difficult to recognize., in Br J Gen Pract, vol. 49, n. 448, novembre 1999, pp. 867-8, PMID 10818648.
FJ. Mackay, NR. Dunn; RD. Mann, Antidepressants and the serotonin syndrome in general practice., in Br J Gen Pract, vol. 49, n. 448, novembre 1999, pp. 871-4, PMID 10818650.
A. Graudins, A. Stearman; B. Chan, Treatment of the serotonin syndrome with cyproheptadine., in J Emerg Med, vol. 16, n. 4, pp. 615-9, PMID 9696181.
GK. Isbister, SJ. Bowe; A. Dawson; IM. Whyte, Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose., in J Toxicol Clin Toxicol, vol. 42, n. 3, 2004, pp. 277-85, PMID 15362595.
RP. Munhoz, Serotonin syndrome induced by a combination of bupropion and SSRIs., in Clin Neuropharmacol, vol. 27, n. 5, pp. 219-22, PMID 15602102.
RA. Ener, SB. Meglathery; WA. Van Decker; RM. Gallagher, Serotonin syndrome and other serotonergic disorders., in Pain Med, vol. 4, n. 1, marzo 2003, pp. 63-74, PMID 12873279.
D. Isenberg, SC. Wong; JA. Curtis, Serotonin syndrome triggered by a single dose of suboxone., in Am J Emerg Med, vol. 26, n. 7, settembre 2008, pp. 840.e3-5, DOI:10.1016/j.ajem.2008.01.039, PMID 18774063.
N. Gnanadesigan, RT. Espinoza; RL. Smith, The serotonin syndrome., in N Engl J Med, vol. 352, n. 23, giugno 2005, pp. 2454-6; author reply 2454-6, PMID 15948273.
D. Bijl, The serotonin syndrome., in Neth J Med, vol. 62, n. 9, ottobre 2004, pp. 309-13, PMID 15635814.
U. Braun, DA. Kalbhen, Evidence for the biogenic formation of amphetamine derivatives from components of nutmeg., in Pharmacology, vol. 9, n. 5, 1973, pp. 312-6, PMID 4737998.
P. Birmes, D. Coppin; L. Schmitt; D. Lauque, Serotonin syndrome: a brief review., in CMAJ, vol. 168, n. 11, maggio 2003, pp. 1439-42, PMID 12771076.
M. Steinberg, AK. Morin, Mild serotonin syndrome associated with concurrent linezolid and fluoxetine., in Am J Health Syst Pharm, vol. 64, n. 1, gennaio 2007, pp. 59-62, DOI:10.2146/ajhp060227, PMID 17189581.
SD. Karki, GR. Masood, Combination risperidone and SSRI-induced serotonin syndrome., in Ann Pharmacother, vol. 37, n. 3, marzo 2003, pp. 388-91, PMID 12639169.
M. Verre, F. Bossio; A. Mammone; M. Piccirillo; F. Tancioni; V. Tortorella; M. Varano, Serotonin syndrome caused by olanzapine and clomipramine., in Minerva Anestesiol, vol. 74, n. 1-2, pp. 41-5, PMID 18004234.
EJ. Dunkley, GK. Isbister; D. Sibbritt; AH. Dawson; IM. Whyte, The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity., in QJM, vol. 96, n. 9, settembre 2003, pp. 635-42, PMID 12925718.
J. Fraser, M. South, Life-threatening fluvoxamine overdose in a 4-year-old child., in Intensive Care Med, vol. 25, n. 5, maggio 1999, p. 548, PMID 10401959.
C. Sun-Edelstein, SJ. Tepper; RE. Shapiro, Drug-induced serotonin syndrome: a review., in Expert Opin Drug Saf, vol. 7, n. 5, settembre 2008, pp. 587-96, DOI:10.1517/14740338.7.5.587, PMID 18759711.
H. Sternbach, The serotonin syndrome., in Am J Psychiatry, vol. 148, n. 6, giugno 1991, pp. 705-13, PMID 2035713.
GK. Isbister, F. Downes; IM. Whyte, Olanzapine and serotonin toxicity., in Psychiatry Clin Neurosci, vol. 57, n. 2, aprile 2003, pp. 241-2, DOI:10.1046/j.1440-1819.2003.01110.x, PMID 12667176.
PK. Gillman, A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status., in Hum Psychopharmacol, vol. 21, n. 2, marzo 2006, pp. 117-25, DOI:10.1002/hup.750, PMID 16342227.
EL. Thorpe, AF. Pizon; MJ. Lynch; J. Boyer, Bupropion induced serotonin syndrome: a case report., in J Med Toxicol, vol. 6, n. 2, giugno 2010, pp. 168-71, DOI:10.1007/s13181-010-0021-x, PMID 20238197.
PK. Gillman, Bupropion, bayesian logic and serotonin toxicity., in J Med Toxicol, vol. 6, n. 2, giugno 2010, pp. 276-7, DOI:10.1007/s13181-010-0084-8, PMID 20440594.
RW. Evans, The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports., in MedGenMed, vol. 9, n. 3, 2007, p. 48, PMID 18092054.
RG. Wenzel, S. Tepper; WE. Korab; F. Freitag, Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?, in Ann Pharmacother, vol. 42, n. 11, novembre 2008, pp. 1692-6, DOI:10.1345/aph.1L260, PMID 18957623.
HS. Duggal, J. Fetchko, Serotonin syndrome and atypical antipsychotics., in Am J Psychiatry, vol. 159, n. 4, aprile 2002, pp. 672-3, PMID 11925312.
PK. Gillman, The serotonin syndrome., in N Engl J Med, vol. 352, n. 23, giugno 2005, pp. 2454-6; author reply 2454-6, PMID 15948272.
K. Laine, T. Heikkinen; U. Ekblad; P. Kero, Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations., in Arch Gen Psychiatry, vol. 60, n. 7, luglio 2003, pp. 720-6, DOI:10.1001/archpsyc.60.7.720, PMID 12860776.
GK. Isbister, A. Dawson; IM. Whyte; FH. Prior; C. Clancy; AJ. Smith, Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?, in Arch Dis Child Fetal Neonatal Ed, vol. 85, n. 2, settembre 2001, pp. F147-8, PMID 11561552.
M. Gill, F. LoVecchio; B. Selden, Serotonin syndrome in a child after a single dose of fluvoxamine., in Ann Emerg Med, vol. 33, n. 4, aprile 1999, pp. 457-9, PMID 10092727.
E. Vuori, JA. Henry; I. Ojanperä; R. Nieminen; T. Savolainen; P. Wahlsten; M. Jäntti, Death following ingestion of MDMA (ecstasy) and moclobemide., in Addiction, vol. 98, n. 3, marzo 2003, pp. 365-8, PMID 12603236.
JA. OATES, A. SJOERDSMA, Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor., in Neurology, vol. 10, dicembre 1960, pp. 1076-8, PMID 13730138.
IM. Whyte, AH. Dawson; NA. Buckley, Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants., in QJM, vol. 96, n. 5, maggio 2003, pp. 369-74, PMID 12702786.
PK. Gillman, The spectrum concept of serotonin toxicity., in Pain Med, vol. 5, n. 2, giugno 2004, pp. 231-2; author reply 233, DOI:10.1111/j.1526-4637.2004.04033.x, PMID 15209988.
U. Hegerl, R. Bottlender; J. Gallinat; HJ. Kuss; M. Ackenheil; HJ. Möller, The serotonin syndrome scale: first results on validity., in Eur Arch Psychiatry Clin Neurosci, vol. 248, n. 2, 1998, pp. 96-103, PMID 9684919.
J. Fennell, M. Hussain, Serotonin syndrome:case report and current concepts., in Ir Med J, vol. 98, n. 5, maggio 2005, pp. 143-4, PMID 16010782.
K. Nisijima, K. Shioda; T. Iwamura, Neuroleptic malignant syndrome and serotonin syndrome., in Prog Brain Res, vol. 162, 2007, pp. 81-104, DOI:10.1016/S0079-6123(06)62006-2, PMID 17645916.
V. Christensen, BY. Glenthøj, [Malignant neuroleptic syndrome or serotonergic syndrome]., in Ugeskr Laeger, vol. 163, n. 3, gennaio 2001, pp. 301-2, PMID 11219110.
KA. Sporer, The serotonin syndrome. Implicated drugs, pathophysiology and management., in Drug Saf, vol. 13, n. 2, agosto 1995, pp. 94-104, PMID 7576268.
PK. Gillman, The serotonin syndrome and its treatment., in J Psychopharmacol, vol. 13, n. 1, 1999, pp. 100-9, PMID 10221364.
K. Nisijima, T. Yoshino; K. Yui; S. Katoh, Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome., in Brain Res, vol. 890, n. 1, gennaio 2001, pp. 23-31, PMID 11164765.
N. Bonetto, L. Santelli; L. Battistin; A. Cagnin, Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum., in Cephalalgia, vol. 27, n. 12, dicembre 2007, pp. 1421-3, DOI:10.1111/j.1468-2982.2007.01430.x, PMID 17868285.
BB. Hanekamp, JG. Zijlstra; JE. Tulleken; JJ. Ligtenberg; TS. van der Werf; LS. Hofstra, Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report., in Neth J Med, vol. 63, n. 8, settembre 2005, pp. 316-8, PMID 16186642.
BC. Prator, Serotonin syndrome., in J Neurosci Nurs, vol. 38, n. 2, aprile 2006, pp. 102-5, PMID 16681290.
E. Jaunay, V. Gaillac; JD. Guelfi, [Serotonin syndrome. Which treatment and when?]., in Presse Med, vol. 30, n. 34, novembre 2001, pp. 1695-700, PMID 11760601.
V. Chechani, Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy., in Crit Care Med, vol. 30, n. 2, febbraio 2002, pp. 473-6, PMID 11889332.
PM. Haddad, Antidepressant discontinuation syndromes., in Drug Saf, vol. 24, n. 3, 2001, pp. 183-97, PMID 11347722.

oadoi.org

EW. Boyer, M. Shannon, The serotonin syndrome., in N Engl J Med, vol. 352, n. 11, marzo 2005, pp. 1112-20, DOI:10.1056/NEJMra041867, PMID 15784664.
PK. Gillman, A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action., in Biol Psychiatry, vol. 59, n. 11, giugno 2006, pp. 1046-51, DOI:10.1016/j.biopsych.2005.11.016, PMID 16460699.
D. Isenberg, SC. Wong; JA. Curtis, Serotonin syndrome triggered by a single dose of suboxone., in Am J Emerg Med, vol. 26, n. 7, settembre 2008, pp. 840.e3-5, DOI:10.1016/j.ajem.2008.01.039, PMID 18774063.
M. Steinberg, AK. Morin, Mild serotonin syndrome associated with concurrent linezolid and fluoxetine., in Am J Health Syst Pharm, vol. 64, n. 1, gennaio 2007, pp. 59-62, DOI:10.2146/ajhp060227, PMID 17189581.
C. Sun-Edelstein, SJ. Tepper; RE. Shapiro, Drug-induced serotonin syndrome: a review., in Expert Opin Drug Saf, vol. 7, n. 5, settembre 2008, pp. 587-96, DOI:10.1517/14740338.7.5.587, PMID 18759711.
GK. Isbister, F. Downes; IM. Whyte, Olanzapine and serotonin toxicity., in Psychiatry Clin Neurosci, vol. 57, n. 2, aprile 2003, pp. 241-2, DOI:10.1046/j.1440-1819.2003.01110.x, PMID 12667176.
EL. Thorpe, AF. Pizon; MJ. Lynch; J. Boyer, Bupropion induced serotonin syndrome: a case report., in J Med Toxicol, vol. 6, n. 2, giugno 2010, pp. 168-71, DOI:10.1007/s13181-010-0021-x, PMID 20238197.
PK. Gillman, Bupropion, bayesian logic and serotonin toxicity., in J Med Toxicol, vol. 6, n. 2, giugno 2010, pp. 276-7, DOI:10.1007/s13181-010-0084-8, PMID 20440594.
K. Laine, T. Heikkinen; U. Ekblad; P. Kero, Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations., in Arch Gen Psychiatry, vol. 60, n. 7, luglio 2003, pp. 720-6, DOI:10.1001/archpsyc.60.7.720, PMID 12860776.
Whyte IM, Dawson AH, Redefining the serotonin syndrome [abstract], in J Toxicol Clin Toxicol, vol. 40, n. 5, 2002, pp. 668–9, DOI:10.1081/CLT-120016859.
PK. Gillman, The spectrum concept of serotonin toxicity., in Pain Med, vol. 5, n. 2, giugno 2004, pp. 231-2; author reply 233, DOI:10.1111/j.1526-4637.2004.04033.x, PMID 15209988.
K. Nisijima, K. Shioda; T. Iwamura, Neuroleptic malignant syndrome and serotonin syndrome., in Prog Brain Res, vol. 162, 2007, pp. 81-104, DOI:10.1016/S0079-6123(06)62006-2, PMID 17645916.
N. Bonetto, L. Santelli; L. Battistin; A. Cagnin, Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum., in Cephalalgia, vol. 27, n. 12, dicembre 2007, pp. 1421-3, DOI:10.1111/j.1468-2982.2007.01430.x, PMID 17868285.

thelancet.com

Turk, Wilson, Cahana., Treatment of chronic non-cancer pain, in Lancet, vol. 377, 2011, DOI:10.1016/S0140-6736(11)60402-9.

web.archive.org

Prescribing Practice Review 32: Managing depression in primary care (PDF), su nps.org.au, National Prescribing Service Limited, 2005. URL consultato il 16 luglio 2006 (archiviato dall'url originale il 27 luglio 2011).